Differential effect of the calmodulin inhibitor trifluoperazine in modulating cellular accumulation, retention and cytotoxicity of doxorubicin in progressively doxorubicin-resistant L1210 mouse leukemia cells
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 37 (2) , 185-193
- https://doi.org/10.1016/0006-2952(88)90716-2
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cellsBritish Journal of Cancer, 1986
- Markedly altered membrane transport and intracellular binding of vincristine in multidrug‐resistant Chinese hamster cells selected for resistance to vinca alkaloidsJournal of Cellular Physiology, 1986
- Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell linesBiochemical Pharmacology, 1986
- Factors governing the modulation of vinca-alkaloid resistance in doxorubicin-resistant cells by the calmodulin inhibitor trifluoperazineBiochemical Pharmacology, 1986
- Genetic and biochemical characterization of multidrug resistancePharmacology & Therapeutics, 1985
- Correlation between potency of calmodulin inhibitors and effects on cellular levels and cytotoxic activity of Doxorubicin (Adriamycin) in resistant P388 mouse leukemia cellsEuropean Journal of Cancer and Clinical Oncology, 1984
- Verapamil Restoration of Daunorubicin Responsiveness in Daunorubicin-resistant Ehrlich Ascites CarcinomaJournal of Clinical Investigation, 1982
- Can calmodulin inhibitors be used to probe calmodulin effects?Biochemical Pharmacology, 1981
- Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemiaBiochemical Pharmacology, 1978
- Adriamycin—A ReviewJNCI Journal of the National Cancer Institute, 1975